Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes.
Jürgens M, Schou M, Hasbak P, Kjaer A, Wolsk E, Zerahn B, Brandt-Jacobsen NH, Gaede P, Rossing P, Faber J, Inzucchi SE, Gustafsson F, Kistorp C. Jürgens M, et al. Among authors: gaede p. Diabetes Obes Metab. 2023 Oct;25(10):2888-2896. doi: 10.1111/dom.15183. Epub 2023 Jul 3. Diabetes Obes Metab. 2023. PMID: 37395341 Clinical Trial.
Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial).
Jürgens M, Schou M, Hasbak P, Kjær A, Wolsk E, Zerahn B, Wiberg M, Brandt NH, Gæde PH, Rossing P, Faber J, Inzucchi S, Gustafsson F, Kistorp CM. Jürgens M, et al. Among authors: gaede ph. BMJ Open. 2019 Nov 27;9(11):e029098. doi: 10.1136/bmjopen-2019-029098. BMJ Open. 2019. PMID: 31780586 Free PMC article.
Effects of Empagliflozin on Myocardial Flow Reserve in Patients With Type 2 Diabetes Mellitus: The SIMPLE Trial.
Jürgens M, Schou M, Hasbak P, Kjær A, Wolsk E, Zerahn B, Wiberg M, Brandt-Jacobsen NH, Gæde P, Rossing P, Faber J, Inzucchi SE, Gustafsson F, Kistorp C. Jürgens M, et al. Among authors: gaede p. J Am Heart Assoc. 2021 Aug 3;10(15):e020418. doi: 10.1161/JAHA.120.020418. Epub 2021 Jul 19. J Am Heart Assoc. 2021. PMID: 34278803 Free PMC article. Clinical Trial.
Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial.
Ersbøll M, Jürgens M, Hasbak P, Kjær A, Wolsk E, Zerahn B, Brandt-Jacobsen NH, Gæde P, Rossing P, Faber J, Inzucchi SE, Gustafsson F, Schou M, Kistorp C. Ersbøll M, et al. Among authors: gaede p. Int J Cardiovasc Imaging. 2022 Mar;38(3):579-587. doi: 10.1007/s10554-021-02443-5. Epub 2021 Oct 20. Int J Cardiovasc Imaging. 2022. PMID: 34669059 Clinical Trial.
Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study.
Oellgaard J, Gæde P, Rossing P, Rørth R, Køber L, Parving HH, Pedersen O. Oellgaard J, et al. Among authors: gaede p. Diabetologia. 2018 Aug;61(8):1724-1733. doi: 10.1007/s00125-018-4642-y. Epub 2018 May 30. Diabetologia. 2018. PMID: 29850922 Free PMC article. Clinical Trial.
112 results